ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 789

The Relationship between YKL-40 and Vascular Endothelial Growth Factor in Angiogenesis in Systemic Sclerosis Patients

Tetsuya Furukawa1, Kiyoshi Matsui2, Masayasu Kitano2 and Naoto Azuma2, 1Division ofRheumatology Department of internal medicine, Hyogo College of Medicine, Nishinomiya, Japan, 2Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Angiogenesis and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc) is an intractable, connective tissue disease that causes fibrosis of the skin and organs and its prognosis is affected by pulmonary arterial hypertension (PAH). SSc presents with Raynaudfs phenomenon as the initial set of symptoms and is often accompanied by nailfold capillary abnormality. SSc is thought to cause microvascular disorder from the early stage. The chitinase-like protein YKL-40 has been implicated in inflammation, tissue remodeling, and angiogenesis in malignant tumors. A previous study in our department demonstrated elevated blood levels of YKL-40 in Japanese SSc patients. Globally, there are no reports examining the relationship between YKL-40 and vascular endothelial growth factor (VEGF) in SSc patients. Immunohistochemical (IHC) staining has not shown a relationship between YKL-40 and SSc in detail. We examined the relationship between YKL-40 and VEGF, which has an important role in angiogenesis.

Methods: We conducted a retrospective analysis of 84 SSc patients who were referred to our institution for treatment between August 2014 and April 2017. We excluded infection and malignant tumor complications. Controls were 15 healthy individuals. We measured serum YKL-40 levels and VEGF levels by ELISA and examined the correlation between YKL-40 age percentile, which was age-corrected for serum YKL-40 levels, and VEGF levels. Additionally, skin biopsy tissues from 7 SSc patients and 7 healthy individuals were also subjected to IHC staining with anti YKL-40 antibody.

Results: Our patient group included 11 men and 73 women with a mean age of 63.1 } 13.4 years and a mean disease duration of 9.6 } 9.8 years. The modified Rodnan total skin thickness score was 6.4 } 6.9. Diffuse cutaneous SSc was identified in 20 patients; limited cutaneous SSc was identified in the other 64 patients. The 15 healthy individuals included 2 men and 13 women with a mean age of 59.7 } 14.7. YKL-40 age percentile and VEGF levels in SSc patients (56.3 } 30.2 and 410.0 } 307.3 pg/ml, respectively) were significantly higher than in healthy individuals (24.9 } 17.4 and 295.0 } 154.5 pg/ml, respectively). The correlation coefficient (0.41) showed a mild correlation between YKL-40 age percentile and VEGF levels in SSc patients. Furthermore, staining of the blood vessel wall of the superficial dermis was found in specimens obtained from all SSc patients.

Conclusion: YKL-40 appears to reflect regeneration after capillary injury in SSc patients, with capillary vessels of the superficial dermis staining with IHC. There is a correlation between serum YKL-40 and VEGF levels in SSc patients.


Disclosure: T. Furukawa, None; K. Matsui, None; M. Kitano, None; N. Azuma, None.

To cite this abstract in AMA style:

Furukawa T, Matsui K, Kitano M, Azuma N. The Relationship between YKL-40 and Vascular Endothelial Growth Factor in Angiogenesis in Systemic Sclerosis Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-relationship-between-ykl-40-and-vascular-endothelial-growth-factor-in-angiogenesis-in-systemic-sclerosis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-relationship-between-ykl-40-and-vascular-endothelial-growth-factor-in-angiogenesis-in-systemic-sclerosis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology